Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Computed inspiratory muscle pressure to monitor inspiratory effort during pressure-targeted assist/control ventilation

Official title: Validation of Computed Inspiratory Muscle Pressure to Monitor Inspiratory Effort During Pressure-Targeted Assist/Control Ventilation: A Prospective Physiological Study

Run by Capital Medical University · NCT07886918 · Data updated 2026-11-12

This study tests a noninvasive computed pressure method (cPmus) to see if it matches the traditional esophageal pressure method for measuring inspiratory effort in adults on pressure-targeted ventilation with spontaneous breathing.

More Critical Care trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorCapital Medical University
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedOctober 22, 2026
Main results expectedApril 30, 2027
Study endsApril 30, 2027
Registry record updatedNovember 9, 2026
Trial IDNCT07886918 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) on pressure-targeted assist/control ventilation who retain spontaneous breathing and can consent or have a legal representative.

Probably not a fit

Patients without spontaneous breaths or those unable to undergo esophageal catheter placement may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective validation study compares a noninvasive cPmus estimate from the ventilator with the reference esophageal-pressure–derived inspiratory muscle pressure (Pmus) in adults receiving pressure-targeted assist/control ventilation with spontaneous breathing. Participants will undergo simultaneous monitoring at four PEEP levels, each maintained for 10 minutes, with additional occlusion maneuvers to gather driving and effort indices. Paired cPmus and Pmus values will be analyzed, along with computed pressure-time products (cPTPmus and PTPmus). Data will be collected in case report forms and an electronic database following standardized procedures. The goal is to determine how closely the noninvasive cPmus tracks the invasive reference across varying PEEP while maintaining a constant inspiratory pressure setting.

Why it matters

Potential benefit: If successful, cPmus could provide a noninvasive, continuous measure of inspiratory effort to guide ventilator settings and potentially reduce risks from inaccurate assessments.

How similar studies have gone: Previous work in this area supports the validity of esophageal-pressure methods; this study aims to extend findings to a noninvasive surrogate with prospective, repeated measurements.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18 years or older.
2. Receiving pressure-targeted assist/control ventilation.
3. Retaining spontaneous breathing.
4. Written informed consent provided by the participant or a legally authorized representative.

Exclusion Criteria:

1. Contraindication to esophageal catheter placement, including uncontrolled coagulopathy, skull base fracture, upper gastrointestinal bleeding, tumor or surgery, neck surgery, or esophagogastric varices.
2. Chest trauma, a postoperative state following lung surgery, an active pulmonary air leak (pneumothorax, pneumomediastinum, or bronchopleural fistula), or an indwelling chest drain.
3. Neuromuscular disease, diaphragmatic dysfunction, or diaphragmatic surgery.
4. Impaired central respiratory drive due to intracranial hypertension or brainstem injury.
5. Hemodynamic instability, defined as mean arterial pressure \<60 mmHg, systolic blood pressure \>180 mmHg, heart rate \<40 or \>150 beats/min, or norepinephrine dose \>1 mcg/kg/min.
6. Pregnancy or breastfeeding.
7. A decision to withdraw life-sustaining treatment or provide palliative care.

Where it's running

  • Beijing Shijitan Hospital
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.